Hepatitis B virus X protein (HBx) has many cellular functions and is a major factor in hepatitis and hepatocellular carcinoma caused by HBV infection. A proteomic approach was used to search for HBxinteracting proteins in order to elucidate the molecular mechanism of hepatocarcinogenesis. HBx was attached to myc and flag tags (MEF tags) and expressed in 293T cells; the protein complex formed within the cells was purified and characterized by mass spectrometry. COP9 signalosome (CSN) subunits 3 and 4 were subsequently identified as HBx-interacting proteins. In addition, CSN subunit 5, Jun activation domain-binding protein 1 (Jab1), was shown to be a novel cellular target of HBx. In vivo and in vitro interactions between HBx and Jab1 were confirmed by standard immunoprecipitation and GST pull-down assays. An analysis of HBx deletion constructs showed that amino acids 30-125 of HBx were responsible for binding to Jab1. Confocal laser microscopy demonstrated that HBx was mainly localized in the cytoplasm, while Jab1 was found mainly in the nucleus and partially in the cytoplasm, and that the two proteins colocalized in the cytoplasm. The cotransfection of HBx and Jab1 resulted in substantial activator protein 1 (AP-1) activation and knockdown of endogenous Jab1 attenuated AP-1 activation caused by HBx. In addition, the coexpression of HBx and Jab1 potentiated phosphorylation of JNK, leading to the subsequent phosphorylation of c-Jun, whereas the level of c-Jun and JNK phosphorylation induced by HBx was decreased in Jab1 knockdown cells. These results suggest that the interaction between HBx and Jab1 enhances HBx-mediated AP-1 activation.
Introduction
Persistent hepatitis B virus (HBV) infection is closely associated with the development of the acute and chronic forms of hepatitis, and with cirrhosis and hepatocellular carcinoma (HCC) (Ganem and Varmus, 1987) . Although worldwide more than 300 million people are chronically infected, the exact molecular mechanism of HBV pathology remains uncertain and an effective treatment for the eradication of HBV has not been found (Omata, 1998) . HBV, a member of the hepadnavirus family, has a partially double-stranded, circular DNA genome consisting of four open reading frames (ORFs) that encode viral proteins. One such ORF, the X gene, encodes the 154-amino-acid HBV X protein (HBx), which has been assigned a variety of cellular functions, including viral infection (Zoulim et al., 1994) , viral replication (Bouchard et al., 2001) , and signal transduction. Moreover, the expression of HBx induces the transformation of murine fibroblasts and causes the development of hepatocellular carcinoma in certain strains of transgenic mice (Shirakata et al., 1989; Kim et al., 1991) , albeit the link between HBx and hepatocarcinogenesis is still controversial.
A number of studies have shown that HBx acts as a transcriptional trans-activator of several cellular and viral genes, including proto-oncogenes, suggesting a mechanism of HCC development. HBx has also been reported to interact with DNA-binding proteins involved in transcriptional regulation, including the TATA-binding protein (Qadri et al., 1995) , the RPB5 subunit (Cheong et al., 1995) , and the cAMP-responseelement-binding protein/transcription-activating protein (CREB/ATF) (Maguire et al., 1991) , and to act as a coactivator of transcription. HBx was also shown to stimulate transcription indirectly by activating cellular signal-transduction pathways, and several transcription elements activated by HBx have been identified, for example, the Ras-Raf-mitogen-activated protein kinase (MAPK) cascade (Benn and Schneider, 1994; Natoli et al., 1994) , that are essential for activator protein 1 (AP-1) activation. The AP-1 transcription factor is a dimeric complex of the Jun (c-Jun, JunB, and JunD), Fos (c-Fos, FosB, Fra1, and Fra2), activating transcription factor (ATF), and musculoaponeurotic fibrosarcoma (Maf) protein families, which recognize either TPA response elements (TRE) or the cAMP response element (CRE).
AP-1 activation is induced by a variety of physical and chemical stresses, including cytokines, growth factors, and bacterial and viral infections. Such stimuli activate the MAP kinase cascade, leading to the activation of MKK4 and MKK7, and the subsequent phosphorylation of c-Jun amino-terminal kinase (JNK) in the cytoplasm. Following these events, JNK translocates to the nucleus and phosphorylates the activation domain of c-Jun at serine residues 63 and 73, leading to the enhancement of its transcriptional activity. AP-1 exerts its oncogenic effects by regulating genes involved in cell proliferation, differentiation, apoptosis, angiogenesis, and tumor invasion (Shaulian and Karin, 2002; Eferl and Wagner, 2003) . The constitutive activation of the MAPK signaling pathway is involved in many types of cancers, including HCC (Ito et al., 1998) , and the precise mechanism of the activation of this pathway by HBx has been explored intensively. HBx activates proline-rich tyrosine kinase-2 (Pyk2) via calcium signaling (Bouchard et al., 2001 ) and the downstream Src family kinase (Klein and Schneider, 1997; Klein et al., 1999) , leading to subsequent Ras-Raf activation (Benn and Schneider, 1994) . Also, HBx has been shown to trigger the N-terminal phosphorylation of c-Jun via activation of JNK, which stimulates the prolonged synthesis of c-Jun (Benn et al., 1996) . Other group has demonstrated that HBx causes the phosphorylation of c-Jun (Ser-63), resulting in AP-1 activation (Henkler et al., 1998) . Furthermore, the sustained activation of JNK and subsequent AP-1 activation was observed in mice transfected with HBx via a virus-mediated delivery system (Nijhara et al., 2001b) .
Although many studies have been reported, the precise mechanism of AP-1 activation by HBx is still not well defined. To investigate the molecular mechanism of hepatocarcinogenesis caused by HBx, we employed a novel tandem affinity purification (MEF) method (Ichimura et al., 2005) and mass spectrometry (MS), which allowed us to identify the COP9 signalosome (CSN) subunits 3 and 4 as novel HBx-binding proteins. CSN was first identified in Arabidopsis thaliana as an eight-subunit complex involved in the suppression of light-dependent development (Wei and Deng, 1999) . Using the yeast two-hybrid system, the fifth CSN subunit, Jun activation domain-binding protein 1 (Jab1), was identified as a binding protein of the activation domain of c-Jun (Claret et al., 1996) , whereby it acts as a coactivator of c-Jun and JunD in the stabilization of the AP-1 complex with its binding sites, thus increasing the specificity of the target-gene activation.
In this study, we demonstrate that HBx directly interacts with Jab1 and that this interaction results in substantial AP-1 activation. The elucidation of this interaction will aid in clarifying the mechanism of hepatocyte proliferation and hepatocarcinogenesis.
Results
Identification of CSN subunits 3 and 4 as HBx-interacting proteins by mass spectrometry To search for HBx-interacting proteins, a novel tandem affinity purification (MEF) method was employed (Ichimura et al., 2005) . This technique uses two different affinity modules (myc and flag) separated by a cleavage site for the TEV protease (myc-TEV-flag). A mammalian expression vector encoding HBx with an amino-terminal MEF tag was constructed and used to transiently transfect 293T cells. Tagged HBx with its binding proteins was then purified from the cell lysate. After the proteins were eluted with flag peptides, they were separated by SDS-PAGE and silver stained. Figure 1 shows the SDS-PAGE profiles Figure 1 Affinity-purified proteins that bind to HBx. 293T cells transfected with pcDNA3-MEF-HBx or pcDNA3-MEF were lysed, and the expressed HBx was recovered using the MEF procedure. The proteins bound to HBx were eluted from the beads, separated by SDS-PAGE (10/20%), and silver stained. Lane 1, pcDNA3-MEF-HBx; lane 2, pcDNA3-MEF. The molecular masses of the protein standards are indicated. The arrowhead indicates the position of HBx. The 12 protein bands were excised from the gel and subjected to in-gel tryptic digestion. The positions of UV-damaged DNA-binding protein 1 (DDB1) (band 1), heatshock protein 70 (band 2), and COP9 signalosome (CSN) subunits 3 and 4 (band 3) are indicated by the arrows.
of the dissociated proteins. The bands in lane 1 (cells transfected with pcDNA3-MEF-HBx) are proteins that directly or indirectly bound to HBx, whereas no proteins were detected in lane 2 (cells transfected with pcDNA3-MEF). The 12 major protein bands were excised from the gel and subjected to in-gel tryptic digestion. The resultant peptides were extracted from the gel slice and analysed using the direct nano-flow LC-MS/MS system, which identified 10 proteins. Among them we detected known targets of HBx, UVdamaged DNA-binding protein 1 (DDB1) (Figure 1 , band 1) (Sitterlin et al., 1997) , and heat-shock protein 70 ( Figure 1 , band 2) (Zhang et al., 2005) , and these interactions were confirmed by immunoprecipitation followed by immnoblot (data not shown). Table 1 describes the identified peptide sequences of the 40 kDa band (Figure 1, band 3) . The most significant hits for this band were obtained with CSN subunits 3 and 4, and this band contained two proteins which had similar molecular weight.
HBx interacts with Jab1 in vivo and in vitro The protein identified by mass spectrometry, CSN, is composed of eight subunits. The CSN complex contains Jab1, a coactivator of c-Jun that activates AP-1 (Claret et al., 1996) . The proteins found on the gel were not Jab1 but had previously been shown to be associated with Jab1 in the CSN complex. As HBx expression also induces AP-1 activation (Benn et al., 1996) , a role for Jab1 in HBx-mediated AP-1 activation was examined by studying the interaction between these two proteins. To investigate whether HBx binds to endogenous Jab1 in a cellular context, HBx was introduced into 293T cells, and immunoprecipitation with anti-flag antibody was performed. As shown in Figure 2a , immunoprecipitation followed by immunoblotting demonstrated that HBx interacted with Jab1 in 293T cells. To examine whether HBx binds to Jab1 in vitro, GST-HBx and GST were incubated with in vitro-translated Jab1, and a pulldown assay was performed. Figure 2b shows that GSTHBx bound to Jab1 in vitro. These results demonstrated that HBx directly interacts with Jab1. The interaction between HBx and Jab1 seems much more efficient in total cell lysates than with protein transcribed and translated in vitro, which suggests that other factors are necessary to stabilize the interaction.
Amino acids 30-125 of HBx are necessary for binding to Jab1 To further characterize the HBx-binding site involved in the interaction with Jab1, immunoprecipitation was carried out using the following deletion mutants of HBx: HBx (1-125), HBx (1-105), , and HBx (61-154) ( Figure 3a) . All of the constructs except HBx (1-105) and HBx (61-154) bound endogenous Jab1 (Figure 3b ). This result was confirmed by carrying out the same experiment using the construct HBx (30-125), followed by immunoprecipitation. Although the interaction was weak, this construct also bound Jab1, indicating that amino acids 30-125 of HBx are necessary for binding to Jab1. It should be noted that the region containing amino acids 30-125 includes part of the transactivation function of HBx (Murakami et al., 1994) . HBx interacts with Jab1 and activates AP-1 Y Tanaka et al
HBx and Jab1 colocalize in the cytoplasm
To assess the subcellular localization of HBx and Jab1, cells were examined by immunocytochemistry using confocal microscopy. pEGFP-X, the GFP-tagged HBx expression vector, was transfected into HeLa cells, and the nuclei were stained with propidium iodide. As reported previously, HBx was mainly localized in the cytoplasm rather than in the nucleus (Henkler et al., 2001) (Figure 4a ), whereas endogenous Jab1 was mainly localized in the nucleus and partially in the cytoplasm ( Figure 4b ). We also investigated the localization of flag-tagged HBx, which had a similar distribution to GFP-tagged HBx (data not shown), and was consistent with a previous report (Doria et al., 1995) . As shown in Figure 4c , the expression of HBx did not affect the main localization of Jab1, although Jab1 in the cytoplasm seems to cluster in the presence of HBx. While a small amount of Jab1 was localized in the cytoplasm, it mostly colocalized with HBx ( Figure 4c ). These results suggest that small but significant part of Jab1 and HBx colocalized in the cytoplasm.
Jab1 facilitates HBx-mediated AP-1 activation
To investigate the effect of Jab1 on HBx-mediated AP-1 activation, HeLa cells were cotransfected with HBx and Jab1 expression plasmids and then assayed for luciferase activity. Biochemical assay revealed that only small amount of overexpressed Jab1 was incorporated into the CSN complex (Naumann et al., 1999) . The introduction of Jab1 alone did not induce significant AP-1 activation (2.070.4 times) ( Figure 5a , lane 2), nor did HBx alone (2.470.6 times) (Figure 5a , lane 3). However, the cotransfection of HBx and Jab1 increased reporter activity to a level 8.271.3 times that of the control (Figure 5a , lane 4) (Po0.05). These data suggest that Jab1, not CSN complex, is involved in HBx-mediated AP-1 activation. To further investigate the role of endogenous Jab1 for AP-1 activation by HBx, we established Jab1 knockdown HeLa cell lines using the stable RNAi and performed luciferase assay. Figure 5b shows the establishment of the Jab1 knockdown (JAB1KD) HeLa cells. Wild-type HeLa cells or JAB1KD HeLa cells were cotransfected with HBx and AP-1 reporter plasmids and then assayed for luciferase activity. As shown in Figure 5c , HBx activated AP-1 in a HBx interacts with Jab1 and activates AP-1 Y Tanaka et al dose-dependent manner, which is consistent with a previous report (Kato et al., 2000) . However, the AP-1 activation in JAB1KD HeLa cells is attenuated (2.370.2 times) compared with wild-type HeLa cells (3.470.1 times) (Po0.05). These results suggest that endogenous Jab1 is partially involved in HBx-mediated AP-1 activation.
Coexpression of HBx and Jab1 potentiates JNK and c-Jun phosphorylation AP-1 activation is induced in part by the phosphorylation of c-Jun (Shaulian and Karin, 2002; Eferl and Wagner, 2003) . To further investigate the mechanism of AP-1 activation by HBx and Jab1, the phosphorylation status of c-Jun was examined. HeLa cells were cotransfected with the HA-tagged c-Jun, HBx, and Jab1 expression vectors. After 24 h, the cells were harvested, proteins were immunoprecipitated with anti-HA antibody, and the level of c-Jun phosphorylation was examined using a phospho-specific antibody.
As previously shown, Jab1 or HBx caused the phosphorylation of c-Jun (Figure 6a , lanes 2 and 3) (Henkler et al., 1998; Kleemann et al., 2000) . In addition, the cotransfection of HBx and Jab1 modestly, but reproducibly, enhanced the phospho-c-Jun level compared with the transfection of HBx or Jab1 only (Figure 6a , lane 4). The phosphorylation level of JNK, an upstream molecule that activates c-Jun, was also investigated. (Figure 7c ), probably because JNK2 phosphorylation induced by HBx was modest (Figures 6c and 7c) . These results suggest that Jab1 binds to HBx and that this interaction potentiates the phosphorylation of JNK and c-Jun, leading to AP-1 activation.
Discussion
In the present study, a novel MEF method applied in combination with nano-flow LC-MS/MS analysis was used to show that CSN subunits 3 and 4 interact with HBx. CSN subunit 5, Jab1, was not directly identified by this technique but assumed present based on the presence of other CSN subunits. The direct binding of HBx with Jab1 and the importance of amino acids 30-125 of HBx in the association with Jab1 were also demonstrated. Furthermore, our results suggest that small but significant fraction of HBx and Jab1 interact in the cytoplasm and that this interaction enhances the phosphorylation of JNK and c-Jun, with subsequent AP-1 activation. The tandem affinity purification method was originally developed to analyse interactions among yeast proteins (Rigaut et al., 1999) . We constructed a mammalian expression vector with two different tags, myc and flag, containing a TEV protease cleavage site (Ichimura et al., 2005) . This technique results in highly purified proteins and a low background. This method enabled us to identify 10 HBx-interacting proteins, and the interactions between HBx and other identified proteins are under investigation. The dual-tag method followed by MS analysis can be used to identify novel protein-protein interactions in mammalian cells.
CSN is composed of eight subunits and is involved in protein phosphorylation (Bech-Otschir et al., 2001; Uhle et al., 2003) , protein degradation (Tomoda et al., 1999) , and deneddylation (Cope et al., 2002) in mammalian cells. Each subunit has been identified as the binding partner of many other proteins and thus has specific functions (Bech-Otschir et al., 2002). We analysed only 12 major protein bands by MS analysis; however other CSN subunits including Jab1 were not identified.
Several groups have reported that the subcellular distribution of HBx is predominantly cytosolic and that a small amount of HBx is localized in the nucleus (Doria et al., 1995; Henkler et al., 2001) . Endogenous Jab1 is mainly incorporated into the CSN complex in the nucleus, but recent studies suggest that Jab1 is also found as a smaller form in the cytoplasm, where it consists of only a subset of CSN components (Oron et al., 2002; Tomoda et al., 2002) . It has also been reported that cytoplasmic, but not nuclear, HBx activates the Ras-Raf-MAPK cascade, leading to AP-1 activation (Doria et al., 1995) . These results support our data on the interaction between HBx and Jab1 in the cytoplasm and subsequent AP-1 activation. Although the main localization of the two molecules differs, immunocytochemistry suggests that HBx interacts with Jab1 in vivo.
We have shown that the induction of HBx and Jab1 causes AP-1 activation. HBx activates AP-1 via two distinct pathways, the Ras-Raf-MAPK and the JNK cascades. HBx stimulates both JNKs and ERKs, leading to the induction and activation of the AP-1 promoter (Benn et al., 1996) . Jab1 was first identified as a coactivator of c-Jun (Claret et al., 1996) , and the expression of Jab1 leads to significant AP-1 activity. However, some groups reported that the overexpression of Jab1 did not greatly affect AP-1 activation (Naumann et al., 1999) . Furthermore, the mechanism of c-Jun activation by Jab1 is still unknown. In the nucleus, Jab1 stabilizes c-Jun together with its promoter region and activates specific gene transcription (Claret et al., 1996) . In the cytoplasm, Jab1 activates JNK and enhances the endogenous phospho-c-Jun level (Kleemann et al., 2000) . However, some groups reported that c-Jun activation caused by CSN is independent of JNK HBx interacts with Jab1 and activates AP-1 Y Tanaka et al (Naumann et al., 1999) . These conflicting results might be owing to the complexity of Jab1 interactions; for example, whether the function of Jab1 involves a CSNindependent or CSN-associated form has not been determined (Chamovitz and Segal, 2001 ). In our study, the coexpression of HBx and Jab1 induced synergistic AP-1 activation to a greater extent than that obtained with HBx or Jab1 alone and knockdown of endogenous Jab1 attenuates AP-1 activation caused by HBx. While only a small portion of Jab1 might interact with HBx in vivo, cytoplasmic Jab1 could bind to HBx and potentiate its activity to phosphorylate JNK. Knockdown of endogenous Jab1 did not lead to complete suppression of AP-1 activation by HBx, thus another pathway such as Ras-Raf-MAPK cascade might be involved in the activation of AP-1. HBx mutant lacking the Jab1-interacting domain (HBx 61-154) still partially activates AP-1 promoter (data not shown), which is consistent with a previous report that HBx 58-140 can still activate AP-1 (Nijhara et al., 2001a) . These data also suggest the involvement of another signaling pathway in AP-1 activation. Whereas ectopically expressed Jab1 was also reported to be associated with protein ubiquitination and degradation, including that of p27 (Tomoda et al., 1999) , HIF 1a (Bae et al., 2002) , and TGFb (Wan et al., 2002) , the coexpression of HBx and Jab1 did not result in these or similar functions (data not shown).
Recently, c-Jun was reported to play an important role in hepatocyte proliferation and apoptosis, and AP-1 was found to be activated in clinical samples of hepatocellular carcinoma and chronic hepatitis (Liu et al., 2002) . Furthermore, a liver-specific c-Jun knockout mouse model revealed that this protein is required in the early stages of tumor development, by preventing apoptosis induced by p53 activity . Taken together, these data suggest that the prolonged expression of HBx leads to sustained AP-1 activation and induces hepatocarcinogenesis.
In conclusion, we have demonstrated that Jab1 interacts with HBx and enhances HBx-mediated AP-1 activation. Our results contribute to elucidating the mechanisms of HBV-mediated hepatocarcinogenesis.
Materials and methods

Cell lines and transfection
The human embryonic kidney cell line 293T and the human cervical carcinoma cell line HeLa were purchased from the Riken Cell Bank (Tsukuba Science City, Japan) and were maintained in Dulbecco's modified Eagle's medium (Sigma, St Louis, MO, USA) containing 10% heat-inactivated fetal bovine serum. The cells were transfected using the Effectene transfection reagent (Qiagen, Hilden, Germany) according to the manufacturer's instructions.
Antibodies
Mouse monoclonal anti-c-myc (EQKLISEEDL) antibody (9E10) conjugated with agarose was obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Mouse monoclonal anti-flag M2 (DYKDDDDK) antibody and its agaroseconjugated form and mouse monoclonal anti-b-actin antibody were purchased from Sigma. The mouse monoclonal anti-HA (hemagglutinin: YPYDVPDYA) antibody (12CA5) was obtained from Roche Diagnostics (Indianapolis, IN, USA) . Mouse monoclonal and rabbit polyclonal anti-Jab1 antibodies were from Genetex (San Antonio, TX, USA) and Santa Cruz Biotechnology, respectively. Rabbit polyclonal anti-phosphoc-Jun (Ser-63) II antibody and anti-phospho-SAPK/JNK (Thr-183/Tyr-185) antibody were purchased from Cell Signaling (Beverly, MA, USA). Alexa Fluor 488 goat anti-rabbit IgG secondary antibody and Alexa Fluor 555 goat anti-rabbit IgG secondary antibody were obtained from Molecular Probes (Eugene, OR, USA). Anti-mouse antibody, anti-rabbit antibody, and streptavidin-conjugated with horseradish peroxidase (HRP) were purchased from Amersham Biosciences (Uppsala, Sweden).
Plasmids
The mammalian expression plasmid for the MEF method, pcDNA3-MEF, was described previously (Ichimura et al., 2005) . Using pCXN2-HBx (Kato et al., 2000) as a template, full-length HBx and its deletion fragments were amplified by PCR with the following sets of primers:
HBx 5 The mammalian expression vector pEF-BOS, which is driven by the elongation factor-1a promoter, was previously described (Mizushima and Nagata, 1990) . Using pCXN2-HBx as a template, full-length HBx was amplified by PCR with the following primers: HBx 5 0 : GCTCTAGAACCATGGCTG CTAGGCTGTGCT, HBx 3 0 : GCTCTAGATTAGGCAGAG GTGAAAAAGT. The PCR products were cloned into the XbaI site of pEF-BOS, producing pEF-BOS-HBx.
The flag-tagged Jab1 expression plasmid pcDNA3-flag-Jab1 was generously provided by David J Mann (Department of Biological Sciences, Imperial College of Science, Technology and Medicine, London, UK) (Chopra et al., 2002) . The EGFPtagged HBx expression plasmid (pEGFP-X) was a gift from Katsuro Koike (Department of Gene Research, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan) (Shirakata and Koike, 2003) . The HA-tagged JNK1, JNK2, and c-Jun expression plasmids were provided by Michael Karin (Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, USA). The GST-fused recombinant HBx plasmid pGEX-HBx was described previously (Tanaka et al., 2004) .
The plasmid pAP-1-Luc, containing the Photinus pyralis (firefly) luciferase reporter gene driven by a basic promoter element (TATA box) plus seven repeats of the binding site for AP-1 (TGACTAA), and pRL-TK, Renilla reniformis (sea pansy) luciferase driven by the herpes simplex virus thymidine kinase promoter, were purchased from Stratagene (La Jolla, CA, USA) and Promega (Madison, WI, USA) respectively.
The short hairpin RNA expression plasmid for stable knockdown under the control of U6 promoter, pcPUR þ U6icassette, was provided by Makoto Miyagishi and Kazunari Taira (Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, Tokyo, Japan) (Miyagishi and Taira, 2002; Jazag et al., 2005) . The sequence for targeting Jab1 was 5 0 -CATGCAGGAAGCTCAGAGTAT-3 0 and pcPUR þ U6-Jab1i was constructed. All constructs were verified by DNA sequencing.
MEF purification MEF purification was carried out as described previously (Ichimura et al., 2005) . Briefly, 293T cells in eight 10 cm dishes (approximately 8 Â 10 7 cells) were transfected with 16 mg of plasmid (pcDNA3-MEF-HBx or pcDNA3-MEF). After 48 h, the cells were harvested with lysis buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% (w/v) glycerol, 100 mM NaF, 10 mM EGTA, 1 mM Na 3 VO 4 , 5 mM ZnCl 2 , 1% (w/v) Triton X-100, and the protease inhibitor cocktail Complete Mini (Roche, Mannheim, Germany)) and centrifuged at 15 000 g for 20 min at 41C. The supernatant was incubated with anti-myc Sepharose for 90 min at 41C and washed five times with TNTG buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 10% (w/v) glycerol, 0.1% (w/v) Triton X-100), twice with buffer A (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% (w/v) Triton X-100), and finally with TNT buffer [50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.1% (w/v) Triton X-100]. The beads were then mixed with 15 U tobacco etch virus (TEV) protease (Invitrogen, Carlsbad, CA, USA) in TNT buffer at room temperature for 1 h to release the protein complex from the beads. The protein complex was incubated with M2-agarose beads for the second immunoprecipitation at room temperature for 1 h and washed with buffer A three times. The beads were subsequently eluted with flag peptide in buffer A (80 mg/ml). The eluted proteins were concentrated, separated by 10/20% SDS-PAGE, and visualized by silver staining, according to a modified protocol (Imamura et al., 2004) .
Tandem mass spectrometry
Proteins were identified as previously described (Natsume et al., 2002; Ichimura et al., 2005) . Protein bands were excised from the gel plate and digested with trypsin, and the resultant peptide fragments were analysed using the direct nano-flow LC-MS/MS system, equipped with an electrospray interface reversed-phase column, a nano-flow gradient device, and a high-resolution quadrupole time-of-flight hybrid mass spectrometer (Q-TOF2; Micromass, Manchester, UK). All of the MS/MS spectra were searched against the nonredundant protein sequence data base maintained at the National Center for Biotechnology Information in order to identify proteins, using the Mascot program (Matrixscience, London, UK). The MS/MS signal assignments were confirmed manually.
Immunoprecipitation and immunoblotting
Immunoprecipitation and immunoblotting were performed as previously described (Kanai et al., 2000) . Cells were lysed in lysis buffer, and cellular proteins were immunoprecipitated with antibody for 1 h at 41C and with protein G-Sepharose (Zymed, San Francisco, CA, USA) overnight at 41C. After the beads were washed with TNE buffer, the bound proteins were eluted by boiling in SDS sample buffer, separated by 10% SDS-PAGE, and electrophoretically transferred to a polyvinylidene difluoride membrane (PVDF) Hybond-P (Amersham Biosciences). The membrane was probed with primary antibody (anti-flag, anti-HA, antiJab1, anti-phospho-c-Jun (Ser-63) II antibody, or anti-phospho-SAPK/JNK (Thr-183/Tyr-185) antibody at 1:1000 dilution) and with secondary antibody (anti-mouse antibody or antirabbit antibody conjugated with HRP at 1:1000 dilution). The HRP signal was detected with enhanced chemiluminescence ECL-plus (Amersham Biosciences).
Expression and purification of recombinant proteins of HBx and in vitro pull-down assay Bead-immobilized GST fusion proteins were prepared as previously described (Tanaka et al., 2004) . In brief, Escherichia coli BL21(DE3) (Stratagene) transformed with pGEX-HBx or pGEX-4T-1 were induced with 1 mM IPTG at 371C for 3 h, pelleted, and lysed in phosphate-buffered saline (PBS) containing 5 mM EDTA, 1 mM DTT, 1 mM PMSF, 100 nM pepstatin, and 1% Triton X-100. The lysates were sonicated and clarified by centrifugation (8000 g for 10 min at 41C). The fusion proteins were purified from the cleared bacterial lysates using glutathione-Sepharose 4B (Amersham Biosciences).
The in vitro transcription and translation of Jab1 were performed using the TNT T7 Coupled Reticulocyte Lysate systems (Promega). Translated Jab1 was incubated with beadimmobilized GST-HBx or GST control beads in lysis buffer overnight at 41C. The beads were washed five times with TNTG buffer, and bound proteins were eluted, separated by 10% SDS-PAGE, and probed with streptavidin conjugated with HRP.
Immunofluorescence microscopy
Immunofluorescence microscopy was carried out as previously described (Tateishi et al., 2001) . HeLa cells were seeded in a slide flask (Nalge Nunc, Naperville, IL, USA) at a density of 3 Â 10 4 cells/cm 2 and transfected with the expression vectors 24 h later. After another 24 h, the cells were fixed with 2% paraformaldehyde for 10 min at room temperature, rinsed with PBS, and permeabilized with 0.25% Triton X-100/PBS for 10 min. The cells were then rinsed with PBS and incubated with rabbit anti-Jab1 polyclonal antibody (1:100 dilution) for 1 h at room temperature, followed by incubation with Alexa Fluor 488 or 555 goat anti-rabbit IgG secondary antibody (1:100 dilution) for 1 h at room temperature. The nuclei of the cells were stained with propidium iodide (Sigma). The cells were mounted with DAKO Fluorescent mounting medium (DAKO, Carpinteria, CA, USA). Fluorescence images were obtained using a Leica TCS SL confocal laser scanning microscope (Leica Microsystems, Wetzler, Germany) and photographed using Leica confocal software (Leica Microsystems).
